Implementierungsleitfaden Therapieziele Onkologie
1.0.0-ballot - Ballot Germany

Implementierungsleitfaden Therapieziele Onkologie - Local Development build (v1.0.0-ballot) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

: Verabreichte adjuvante Systemtherapie – Pembrolizumab-Monotherapie, Zyklus 1/~9 (Beispiel)

Raw json | Download

{
  "resourceType" : "MedicationAdministration",
  "id" : "MedicationAdministrationPembroAdjuvantMamma1",
  "language" : "de",
  "text" : {
    "status" : "generated",
    "div" : "<div xml:lang=\"de\" lang=\"de\"><hr/><p><b>German</b></p><hr/><p class=\"res-header-id\"><b>Generated Narrative: MedicationAdministration MedicationAdministrationPembroAdjuvantMamma1</b></p><a name=\"MedicationAdministrationPembroAdjuvantMamma1\"> </a><a name=\"hcMedicationAdministrationPembroAdjuvantMamma1\"> </a><p><b>status</b>: Completed</p><p><b>medication</b>: <span title=\"Codes:\">Pembrolizumab-Monotherapie (adjuvant, KEYNOTE-522), q3w</span></p><p><b>subject</b>: <a href=\"Patient-PatientinMamma.html\">Sabine Baumann  Female, DoB: 1977-06-24</a></p><p><b>effective</b>: 2026-04-24</p><p><b>request</b>: <a href=\"MedicationRequest-MedicationRequestPembroAdjuvantMamma.html\">MedicationRequest: extension = Same LoT; status = active; intent = plan; category = Tumor board Consult note; medication[x] = </a></p><p><b>note</b>: </p><blockquote><div><p>Zyklus 1 von ~9 (q3w), ambulant</p>\n</div></blockquote></div>"
  },
  "status" : "completed",
  "medicationCodeableConcept" : {
    "text" : "Pembrolizumab-Monotherapie (adjuvant, KEYNOTE-522), q3w"
  },
  "subject" : {
    🔗 "reference" : "Patient/PatientinMamma"
  },
  "effectiveDateTime" : "2026-04-24",
  "request" : {
    🔗 "reference" : "MedicationRequest/MedicationRequestPembroAdjuvantMamma"
  },
  "note" : [
    {
      "text" : "Zyklus 1 von ~9 (q3w), ambulant"
    }
  ]
}